Bronchial artery chemoembolization with apatinib for treatment of central lung squamous cell carcinoma
Authors:
- 27 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cancer Research and Therapeutics
- Vol. 18 (5) , 1432-1435
Abstract
Objective: To evaluation the clinical efficacy and safety of bronchial artery chemoembolization (BACE) combined with apatinib for treatment of advanced central lung squamous cell carcinoma (LSCC). Methods: Forty-seven patients with pathologically diagnosed stage IIIB or IV central LSCC that was not resectable were selected among hospital patients presenting after November 2016. Twenty-one patients were treated with BACE combined with apatinib; the remaining patients served as a control group treated with BACE alone. Objective response rate (ORR) and disease control rate (DCR) were evaluated with postoperative contrast-enhanced CT scans at 3, 6, and 12 months. Progression-free survival (PFS) curves were used to evaluate curative effects. Adverse events were recorded to assess safety. Results: BACE operations were successfully completed in all 47 patients. Significant differences were found at six and 12 months (P < 0.05). Median PFS was 322 days in the observation group and 209 days in the control group: a statistically significant difference (P = 0.042). One-year survival rates were 76.19% and 46.15% for observation and control patients, respectively; this difference was also significant (P = 0.037). Three patients in the observation group received emergency interventional embolization for hemoptysis, and patients with grade III or greater adverse reaction events (AE) accounted for 19.05% of patients (4/21); these subjects improved or were controlled after active treatment. Conclusion: BACE combined with apatinib is effective for treatment of advanced central LSCC, with definite short-term efficacy, controllable risk, and high safety. Investigation with a larger sample size is warranted to confirm study results.Keywords
This publication has 12 references indexed in Scilit:
- Transarterial management of advance lung cancerJapanese Journal of Clinical Oncology, 2021
- Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancerPostgraduate Medicine, 2020
- The efficacy of drug‐eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non‐small cell lung cancerThoracic Cancer, 2019
- Apatinib and S-1 combination therapy for the treatment of advanced head and neck neoplasms: Three case reportsJournal of Cancer Research and Therapeutics, 2019
- Angiogenesis and apatinibJournal of Cancer Research and Therapeutics, 2018
- Apatinib for advanced nonsmall-cell lung cancerJournal of Cancer Research and Therapeutics, 2018
- The role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trialsJournal of Cancer Research and Therapeutics, 2016
- Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survivalLa radiologia medica, 2016
- Immediate and Late Outcomes of Bronchial and Systemic Artery Embolization for Palliative Treatment of Patients With Nonsmall-Cell Lung Cancer Having HemoptysisAmerican Journal of Hospice and Palliative Medicine®, 2013
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung CancerScience Translational Medicine, 2010